|Last Price$0.22||Day Change (%)-17.70%|
|Open Price$0.22||Day Change ($)-0.05|
|Day Range0.22–0.27||52-Week Range0.13–7.20|
As of Wed 09/17/2014 02:46 PM EST | USD
Research and Markets: Global Cell Culture Market Forecasts and Opportunities, 2018
Synthetic Biologics Highlights New Data from C. difficile Program Presented at the 54th ICAAC
TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension
Mylan Launches First Generic Klor-Con® Extended-Release Tablets
Mylan Launches Generic Precedex™ Injection - Another Key Product Approval
Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.
IMS Health is on the right track for growth.
A look back at the winners and losers of the final quarter of a tumultuous year.